Login / Signup

Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes.

Lindsey WangNathan A BergerDavid C KaelberRong Xu
Published in: Gastroenterology (2024)
GLP-1RAs were associated with a reduced risk of incident HCC and hepatic decompensation compared with other anti-diabetes medications in patients with T2DM. These findings provide supporting evidence for future studies to investigate the underlying mechanisms and their clinical use.
Keyphrases
  • cardiovascular disease
  • type diabetes
  • glycemic control
  • risk factors
  • current status
  • case control
  • wild type
  • metabolic syndrome
  • skeletal muscle
  • insulin resistance